Prenatal Screening Using QF-PCR and Karyotyping with an Evaluation of Short Tandem Repeats Markers in the Iranian Population

Document Type : Original Article

Authors

1 Mother and Newborn Health Research Center, Shahid Sadoughi Hospital, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Dr. Mazaheri’s Medical Genetics Lab, Yazd, Iran

4 Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background: Quantitative fluorescent Polymerase Chain Reaction (QF-PCR) has been widely used by laboratories as a rapid, low-cost, and convenient test compared to conventional karyotyping for detecting the most common aneuploidies for prenatal diagnosis. Although the latter has been considered the gold standard for detection, the debate to use QF-PCR or both methods together continues. We screened the results of QF-PCR and karyotyping to compare their detection rate for the most common aneuploidies. In addition, we aimed to investigate the most informative markers in the Iranian population for aneuploidies. 
Methods: We screened 741 pregnant women’s amniotic fluid samples with nuchal translucency (NT) ≥2.5 for two years, during which QF-PCR and karyotyping were performed to compare the results. Also, we did a statistical assessment of samples for heterozygosity of 25 short tandem repeats (STR) markers in the Iranian population, which can be applied to find the most informative markers based on the population for each chromosome analyzed in the QF-PCR test.
Results: The QF-PCR results were 99.8, consistent with the results of cytogenetic analysis, and just one case could not be detected with QF-PCR due to mosaicism.  Among the evaluated markers in this study, D13S258, D18S51, and D21S1411 had the highest frequency of heterozygosity.
Conclusion: QF-PCR could be used as a stand-alone test to reduce the workload and time-consuming of karyotyping, but using both of them could lead us to the most reliable results.

 
 

Keywords


Corresponding Author: Mahta Mazaheri
View Orcid in Profile
You can search for this author in PubMed     Google Scholar Profile

1. Masoudzadeh N, Teimourian S. Comparison of quantitative fluorescent polymerase chain reaction and karyotype analysis for prenatal screening of chromosomal aneuploidies in 270 amniotic fluid samples. J Perinat Med 2019; 47(6): 631-6.
2. Nagaoka SI, Hassold TJ, Hunt PA. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat Rev Genet 2012; 13(7): 493-504.
3. Dey M, Sharma S, Aggarwal S. Prenatal screening methods for aneuploidies. N Am J Med Sci 2013; 5(3): 182-90.
4. Muthuswamy S, Agarwal S. Segmental duplication QF-PCR: A simple and alternative method of rapid aneuploidy testing for developing country like India. J Clin Lab Anal 2017; 31(2): e22038.
5. Jing X, Liu H, Zhu Q, Liu S, Liu J, Bai T, et al. Clinical selection of prenatal diagnostic techniques following positive noninvasive prenatal screening results in Southwest China. Front Genet 2022; 12: 811414.
6. Muthuswamy S, Bhalla P, Agarwal S, Phadke SR. Performance of QF-PCR in targeted prenatal aneuploidy diagnosis: Indian scenario. Gene 2015; 562(1): 55-61.
7. Grati FR, Malvestiti F, Grimi B, Gaetani E, Meco AM Di, Trotta A, et al. QF-PCR as a substitute for karyotyping of cytotrophoblast for the analysis of chorionic villi: Advantages and limitations from a cytogenetic retrospective audit of 44,727 first-trimester prenatal diagnoses. Prenat Diagn 2013; 33(5): 502-8.
8. Rostami P, Valizadegan S, Ghalandary M, Mehrjouy MM, Esmail-Nia G, Khalili S, et al. Prenatal screening for aneuploidies using QF-PCR and karyotyping: A comprehensive study in Iranian population. Arch Iran Med 2015; 18(5): 296-303.
9. Zhang H, Xu Z, Chen Q, Chen H, Ding X, Liu L, et al. Comparison of the combined use of CNV-seq and karyotyping or QF-PCR in prenatal diagnosis: a retrospective study. Sci Rep 2023; 13(1): 1862.
10. Asadollahi S, Mazaheri M, Tabatabaee RS, Khajehnoori S, Noorishadkam M, Mirjalili M, et al. A survey on leading indications of fetomaternal therapeutic abortions in Yazd: A cross sectional study. World J Peri Neonatol 2020; 2(2): 61-6.
11. Khajehnoori S, Tabatabaee RS, Noori-Shadkam M, Lookzadeh MH, Mojibian M, Mirjalili M, et al. Prevalence of fetomaternal indications of therapeutic abortions in Yazd Province. World J Peri Neonatol 2020; 2(1): 1-8.
12. Shirgholami N, Abdi F, Mazaheri M, Tabatabaee RS. Amniocentesis complications in Yazd Baghaeipour Polyclinic: A cross-sectional study. World J Peri Neonatol 2020; 3(1): 12-8.
13. Alivand R, Abdi F, Dehghani-Ashkezari M, Neamatzadeh H, Ekraminasab S. Association of +505A>G polymorphism at TAFI gene with recurrent miscarriage in Iranian women. World J Peri Neonatol 2020; 3(2): 62-8.
14. Farzan F, Dadbinpour A, Ekraminasab S, Fallahzadeh H, Mazaheri M. Positive predictive value of screening tests in the first and second trimester of pregnancy in the diagnosis of trisomy 21, 18, and 13 using amniocentesis. World J Peri Neonatol 2022; 5(2): 74-82.
15. Manasatienkij C, Nimnual A, Jantarasaengaram S. Accuracy of prenatal diagnosis of common aneuploidies using QF-PCR comparing with standard karyotyping in Thai pregnant women. J Health Sc 2022; 31(Suppl 2): 341-52.
16. Miri MR, Saberzadeh J, Behbahani AB, Tabei MB, Alipour M, Fardaei M. Segmental duplications as a complement strategy to short tandem repeats in the prenatal diagnosis of Down syndrome. Iran J Med Sci 2019; 44(3): 214-9.
17. Nasiri H, Noori-Dalooi MR, Dastan J, Ghaffari SR. Investigation of QF-PCR application for rapid prenatal diagnosis of chromosomal aneuploidies In the Iranian population. Iran J Pediatr 2011; 21(1): 15-20.
18. Badenas C, Rodríguez-Revenga L, Morales C, Mediano C, Plaja A, Pérez-Iribarne MM, et al. Assessment of QF-PCR as the first approach in prenatal diagnosis. J Mol Diagn 2010; 12(6): 828-34.
19. De Moraes RW, De Carvalho MHB, De Amorim-Filho AG, Francisco RPV, Romão RM, Levi JE, et al. Validation of QF-PCR for prenatal diagnoses in a Brazilian population. Clinics (Sao Paulo) 2017; 72(7): 400-4.
20. Kaya ÖÖ, Koç A, Özdemir TR, Kirbiyik Ö, Özyilmaz B, Özeren M, et al. Qf-PCR in invasive prenatal diagnosis: A single-center experience in Turkey. Turk J Med Sci 2017; 47(1): 142-7.
21. Saberzadeh J, Miri MR, Tabei MB, Dianatpour M, Fardaei M. Genetic variations of 21 STR markers on chromosomes 13, 18, 21, X, and Y in the south Iranian population. Genet Mol Res 2016; 15(4): 1-9.